Published 16 hours ago • loading... • Updated 1 hour ago

Novo Holdings-Backed Windward Bio Raises $175 Million in US IPO

Summary by WTVB

Nov 12 (Reuters) - Novo Holdings-backed Windward Bio said on Thursday it had raised $175 million in its US initial public offering after selling about 10.3 million shares ‌at $17 apiece. The IPO price was within its marketed range of $16 to $18. Basel...

7 Articles

Reuters

+2 Reposted by 2 other sources

Center

Novo Holdings-backed Windward Bio raises $175 million in US IPO

1 hour ago·London, United Kingdom

Read Full Article

Globe Newswire

Reposted by

stocktitan.net

Center

Windward Bio Announces Pricing of Initial Public Offering

BASEL, Switzerland, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG (“Windward”) (Nasdaq: WWB), a clinical-stage biotechnology company developing...

13 hours ago

Read Full Article

biopharmadive.com

Center

Windward prices $175M IPO to advance China-licensed lung drugs

The Swiss biotech has two prospects it sees as having the potential to outcompete AstraZeneca and Amgen's blockbuster asthma treatment Tezspire.

16 hours ago

Read Full Article

Bloomberg

Center

Swiss Biotech Windward Raises $225 Million in US IPO, Placement

Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.

24 hours ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year